Megan Waldrop, MD

Megan Waldrop, MD, is a pediatric neurologist at Nationwide Children’s Hospital and an Associate Professor of Pediatrics and Neurology at The Ohio State University College of Medicine. She completed her Pediatrics and Child Neurology training at the Children’s Hospital of Orange County/University of California, Irvine School of Medicine. She completed a Neuromuscular Medicine fellowship at Ohio State University/Nationwide Children’s Hospital and a Neuromuscular Genetics Therapeutics fellowship at Nationwide Children’s Hospital.
She is board certified in Neuromuscular Medicine and Neurology with special qualifications in Child Neurology. Her clinical and research interests include identifying transformative therapies for neuromuscular conditions, with a particular interest in equitable access to diagnosis and treatment.
Financial relationships
-
Attribution:SelfType of financial relationship:AdvisorIneligible company:Sarepta TherapeuticsTopic:DMD/elevidysDate added:07/23/2026Date updated:07/23/2026Relationship end date:12/31/2025
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:Syneos HealthTopic:vamorolone and dermatomyositisDate added:07/23/2026Date updated:07/23/2026Relationship end date:06/30/2025
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:Sarepta TherapeuticsTopic:improving time to diagnosis in DMDDate added:07/23/2026Date updated:07/23/2026
-
Attribution:SelfType of financial relationship:AdvisorIneligible company:SOLID BiosciencesTopic:DMD gene therapyDate added:07/23/2026Date updated:07/23/2026Relationship end date:11/30/2025
-
Attribution:SelfType of financial relationship:AdvisorIneligible company:Roche GenentechTopic:SMA fetal risdiplam useDate added:07/23/2026Date updated:07/23/2026Relationship end date:01/31/2026
-
Attribution:SelfType of financial relationship:AdvisorIneligible company:GemmaBioTopic:IDMC member for SMA gene therapy productDate added:07/23/2026Date updated:07/23/2026
-
Attribution:SelfType of financial relationship:ResearcherIneligible company:Sarepta TherapeuticsTopic:Site PIDate added:07/23/2026Date updated:07/23/2026
-
Attribution:SelfType of financial relationship:ResearcherIneligible company:Novartis Gene TherapiesTopic:Site PIDate added:07/23/2026Date updated:07/23/2026
-
Attribution:SelfType of financial relationship:ResearcherIneligible company:Scholar RockTopic:Site PIDate added:07/23/2026Date updated:07/23/2026
-
Attribution:SelfType of financial relationship:ResearcherIneligible company:BiohavenTopic:Site PIDate added:07/23/2026Date updated:07/23/2026

Facebook
X
LinkedIn
Forward